ArticleThoracic cancer2023

Efficacy of lazertinib for symptomatic or asymptomatic brain metastases in treatment-naive patients with advanced EGFR mutation-positive non-small cell lung cancer: Protocol of an open-label, single-arm phase II trial.

Bora Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.